Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Cell Therapy Market Size Set to More Than Double by 2030 -- North America Leads, While Asia-Pacific Emerges as the Fastest-Growing Region, Says Mordor Intelligence

prnewswire.com
NVS Novartis AG is mentioned as a major company operating in the CAR T-Cell Therapy market, which is part of the broader cell therapy market projected for significant growth. The article does not provide specific sentiment towards Novartis itself, but its inclusion in a growing market is generally positive. BMY JNJ SRPT Sorrento Therapeutics, Inc. is named as a major company in the CAR T-Cell Therapy market. The article's positive outlook on the cell therapy sector suggests potential growth opportunities for Sorrento, although no specific sentiment is detailed. GILD Gilead Sciences, Inc. (Kite Pharma) is mentioned as a major company in the CAR T-Cell Therapy market. The article's positive projection for the cell therapy market suggests a potentially beneficial landscape for Gilead's operations in this area. TMO Thermo Fisher Scientific is listed as a major company in the Cell Culture Market, which is related to the broader cell therapy market. The article's positive outlook on the cell therapy sector suggests potential benefits for Thermo Fisher's business. DHR Danaher Corporation is mentioned as a major company in the Cell Culture Market. The article's positive forecast for the cell therapy market implies a potentially favorable environment for Danaher's contributions to this sector. SART MRK Merck KGaA is listed as a major company in the Cell Culture Market. The article's positive outlook on the cell therapy market suggests a potentially beneficial environment for Merck KGaA's operations in related fields. BDX Becton, Dickinson and Company is named as a major company in the Cell Culture Market. The article's positive forecast for the cell therapy market implies potential growth and opportunities for Becton, Dickinson and Company.

HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ -- According to Mordor Intelligence, the cell therapy market is valued at USD 5.5 billion in 2025 and is projected to surpass USD 12.2 billion by 2030, advancing at an 17.05% CAGR, driven by rising commercialization of advanced therapies, increasing investment in manufacturing capacity, and significant progress in allogeneic, off-the-shelf treatment platforms. Growing demand for personalized and regenerative treatment options, combined with regulatory support for breakthrough therapies, continues to propel the market into a high-growth phase. As biopharmaceutical companies accelerate the development of scalable and next-generation cell therapy solutions, the sector is transitioning from early-stage innovation to broader clinical and commercial integration.

Regional Market Insights

North America continues to lead the global cell therapy market due to strong regulatory pathways, advanced manufacturing infrastructure, and high investment in R&D. The United States remains at the forefront of CAR-T development, allogeneic platform research, and commercialization of next-generation therapies.

Asia-Pacific is projected to grow at the fastest pace through 2030, supported by rising clinical trial activity, cost-efficient production capabilities, and increasing government initiatives to strengthen biotechnology innovation. Countries such as China, Japan, and South Korea are accelerating approvals and expanding research ecosystems for cell-based therapies.

Emerging Key Trends

Rapid Commercialization of Autologous Therapies

Autologous therapies have gained strong clinical traction as personalized treatment solutions, especially in oncology. Their increasing regulatory approvals and expanding real-world evidence base are encouraging providers and payers to integrate these therapies into routine treatment pathways. Faster production workflows and optimized patient cell-collection methods are further improving accessibility.

Expansion Beyond Oncology into Regenerative & Immune Disorders

While oncology remains the leading application segment, cell therapy is expanding into autoimmune, cardiovascular, neurological, and musculoskeletal indications. This diversification is broadening the treatment landscape and creating new opportunities for research organizations and developers targeting unmet medical needs.

Comprehensive Market Segmentation Overview

By Therapy Type

By Cell Type

Immune Cell Therapy

By Application

By End User

By Geography

For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/cell-therapy-market?utm_source=prnewswire

Competitive Environment

The cell therapy market is moderately consolidated, with global biotechnology leaders and emerging specialists contributing to a highly competitive and innovation-driven ecosystem. Companies are prioritizing advancements in gene-modified cells, off-the-shelf therapeutic platforms, and automated production technologies. Strategic collaborations, licensing agreements, and investment in AI-enabled manufacturing are becoming key approaches to expand development pipelines and accelerate commercialization.

Key Companies in the Cell Therapy Include:

Check out related reports published by Mordor Intelligence:

CAR T-Cell Therapy Market: The CAR T-Cell Therapy Market is Segmented by Target Antigen (CD19, BCMA, CD22, GD2), Type (Abecma, Breyanzi), Cell Source (Autologous and Allogenic), Application (Leukemia, Lymphoma), End User (Hospitals, Cancer Care Treatment Centers), and Geography (North America, Europe, Asia-Pacific).

Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson, Sorrento Therapeutics, Inc. and Gilead Sciences, Inc. (Kite Pharma) are the major companies operating in this market.

Read more about companies active in CAR T-Cell Therapy: https://www.mordorintelligence.com/industry-reports/car-t-cell-therapy/companies?utm_source=prnewswire

Cell Culture Market: The Cell Culture Market Report is Segmented by Product (Equipment and Consumables), Cell Type (Mammalian Cells), Technology (2-D Cell Culture and 3-D Cell Culture), Application (Biopharmaceutical Production, Drug Discovery & Development), End-User (Pharmaceutical & Biotechnology Companies), and Geography (North America, Europe).

Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA and Becton, Dickson and Company are the major companies operating in this market.

Read more about companies active in Cell Culture: https://www.mordorintelligence.com/industry-reports/cell-culture-market/companies?utm_source=prnewswire

Gene Therapy Market: The Gene Therapy Market Report Segments the Industry Into by Vector Type (Adeno Virus Vector), Indication (Oncology, Rare Metabolic Disorders, and More), Delivery Mode (In Vivo Gene Delivery and Ex Vivo Gene Delivery), End User (Hospitals and Clinics), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, South America).

About Mordor Intelligence:

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.

For any inquiries, please contact:

media@mordorintelligence.com

https://www.mordorintelligence.com/contact-us

Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg

SOURCE Mordor Intelligence Private Limited